News

Articles

April 22, 2019

BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats

Amylin analogs are important adjunctive drugs in the treatment of diabetes mellitus. However, a dual therapy with insulin involves inconvenient multiple injections. Here we describe a novel n-terminal PEGylated human amylin analog – BZ043 – and its potential to improve the control of glycemia using lower doses of insulin. The effect of BZ043 over the insulin-mediated control of fed-glycemia was investigated in rats with streptozotocin-induced diabetes treated with the basal analog glargine (GLAR). Fasted rats (3 h) received a single treatment of BZ043 (16, 64 or 128 nmol/kg), GLAR (1.5 IU or 6.0 IU) or BZ043 plus GLAR low dose (1.5 IU) in separate injections, and had free access to 5% glucose rich chow and water. BZ043 dose-proportionally prevented the meal-related increase of glycemia, and the co-treatment (64 or 128 nmol/kg) with GLAR restored normoglycemia without abrupt variations of glycemia. BZ043 showed a prolonged anti-hyperglycemic effect and, together with GLAR, promoted a long-lasting normoglycemia, in vivo. We conceive that combining BZ043 and GLAR in a fixed-ratio co-formulation might conveniently improve the control of diabetes mellitus.
 
Access the full paper co-authored by our patent specialist Caio França by clicking here.
Back

Last related news

November 9, 2022

Brazil: Patent Litigation 2023 – IAM Media

Our partner Claudio Barbosa and our Attorney at Law Viviane Trojan are the authors of the article “Brazil: Patent Litigation”, published in the Global Patent Brazil: Patent Litigation 2023 – IAM Media

Ler notícia

August 15, 2022

Protecting Plant Varieties in Brazil for FloraCulture Magazine

Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant Protecting Plant Varieties in Brazil for FloraCulture Magazine

Ler notícia

February 14, 2022

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that Life sciences patent eligibility in Latin America: a guide

Ler notícia